Key facts
- This page summarizes Timothy Maness's Form 4 filing for ADAPTIN BIO, INC..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 10 Sep 2025, 16:59.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
50% of the stock option vested on September 8, 2025. The remaining 50% of the stock option vests in equal monthly installments on the last day of each calendar month over 48 months, beginning on September 8, 2025.